Fluticasone furoate
chemical compound

Fluticasone furoate, sold under the brand name Flonase Sensimist among others, is a corticosteroid for the treatment of non-allergic and allergic rhinitis administered by a nasal spray. It is also available as an inhaled corticosteroid to help prevent and control symptoms of asthma. It is derived from cortisol. Unlike fluticasone propionate, which is only approved for children four years and older, fluticasone furoate is approved in children as young as two years of age when used for allergies.
It was approved for medical use in the United States in April 2007, and in the European Union in November 2008. In 2023, fluticasone was the 26th most commonly prescribed medication in the United States, with more than 21 million prescriptions.
Medical uses
Fluticasone furoate is indicated for the treatment of the symptoms of allergic rhinitis and asthma.
Fluticasone furoate is a corticosteroid medication primarily used to treat allergic rhinitis (hay fever) and non-allergic (perennial) rhinitis. It is also indicated for the treatment of nasal polyps in adults. Additionally, fluticasone furoate nasal spray may be prescribed for the management of symptoms associated with sinusitis.
“Fluticasone furoate” enters the record as chemical compound. Crown Archives preserves that source wording while asking what Fluticasone, furoate and chemical can confirm, complicate or overturn.
Why this record matters
“Fluticasone furoate” is worth following because a concise public description often conceals a longer documentary argument. Here, Fluticasone, furoate and chemical provides the most credible route into that argument.
Datasets, specimens, observations and peer-reviewed methods provide the appropriate test for the technical claims summarized here. The source revision retrieved here is dated Sep 8, 2026. The linked authority identifier is Q2166700. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2007, 2008 and 2023.
Current terminology should not be projected backward without checking the classification used when the underlying evidence was created. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “Fluticasone furoate”, its source revision and the description used here.
- Expand the search: follow Fluticasone furoate primary sources, Fluticasone furoate archive and Fluticasone research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Fluticasone furoate”?
- Is the terminology current, historical or disputed?
- Has classification or technical consensus changed since the cited source?
Search terms from this dossier
This entry incorporates text from “Fluticasone furoate” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.